validated automated edge detection algorithm cms version 7.1 (Medis)
90
Structured Review
Medis
validated automated edge detection algorithm cms version 7.1
Validated Automated Edge Detection Algorithm Cms Version 7.1, supplied by Medis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/validated+automated+edge+detection+algorithm+cms+version+7%2E1/automated+edge+detection+system+cms/pm32399662-66-19-25
Average 90 stars, based on 1 article reviews
Validated Automated Edge Detection Algorithm Cms Version 7.1, supplied by Medis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/validated+automated+edge+detection+algorithm+cms+version+7%2E1/automated+edge+detection+system+cms/pm32399662-66-19-25
Average 90 stars, based on 1 article reviews
validated automated edge detection algorithm cms version 7.1 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Imaging:Article Title: Empagliflozin attenuates neointimal hyperplasia after drug-eluting-stent implantation in patients with type 2 diabetes. Article Snippet: The effects of empagliflozin, a sodium-glucose co-transporter 2 inhibitor, on neointimal response after drug-eluting-stent (DES) implantation remains unknown.. Insufficiently controlled diabetes patients with coronary artery disease planned for DES stenting were consecutively enrolled.. The patients were assigned to receive empagliflozin in addition to standard therapy or intensive therapy using other glucose-lowering drugs (oGLD). |